Highest-materiality recent filing
Proto Labs shareholders approve 395,000-share increase to 2022 LTIP
Shareholders re-elected all seven director nominees (Suresh Krishna, Archie Black, Sujeet Chand, Moonhie Chin, Rainer Gawlick, Donald Krantz, Sven Wehrwein).
Proto Labs COO retiring July 1; appoints Bernardo Parlange as new CCO
COO Mike Kenison to retire effective July 1, 2026, after ~20 years at the company.
Protolabs Q1 revenue record $139.3M (+10.4% YoY); GAAP EPS $0.33, non-GAAP $0.54
Revenue $139.3M record, up 10.4% YoY; CNC machining revenue +19.7% YoY.
Proto Labs corrects Q1 2026 GAAP diluted EPS guidance to $0.18-$0.26
Correction of scrivener's error in Q1 2026 GAAP diluted EPS guidance: previously $0.17-$0.25, now $0.18-$0.26.
Protolabs reports record Q4 revenue $136.5M, net income $6.0M; CNC machining up 25% YoY
Record Q4 revenue $136.5M (+12.1% YoY); full-year revenue $533.1M (+6.4% YoY).
Protolabs Q3 2025 record revenue $135.4M, up 7.8% YoY; EPS $0.30 GAAP, $0.47 non-GAAP
Record quarterly revenue of $135.4M, +7.8% YoY from $125.6M.
Proto Labs names Marc Kermisch CTO & AI Officer, effective Oct 13; Ryaboy departs Nov 2
Oleg Ryaboy steps down as CTO, effective November 2, 2025; receives severance per executive agreement.
Proto Labs reports record Q2 revenue of $135.1M, up 7.5% YoY; non-GAAP EPS $0.41
Revenue $135.1M (+7.5% YoY); net income $4.4M roughly flat vs prior year.
Former CEO Robert Bodor signs consulting deal with Proto Labs at $5k/month through Nov 2025
Robert Bodor ceased as President and CEO effective May 20, 2025; consulting agreement signed May 28.
Protolabs appoints Suresh Krishna as CEO; reaffirms Q2 2025 guidance
Suresh Krishna appointed President, CEO, and director effective May 20, 2025, succeeding Robert Bodor.
Proto Labs Q1 revenue $126.2M (-1.3% YoY); GAAP EPS $0.15, non-GAAP EPS $0.33
Revenue of $126.2M down from $127.9M in Q1 2024; Network revenue grew 10% to $26.3M.
Proto Labs FY2024 revenue $501M, GAAP EPS $0.66; Q4 net loss $0.4M; authorizes $100M buyback
Q4 revenue $121.8M (-2.6% YoY); net loss of $0.4M (GAAP diluted EPS -$0.02) vs net income $7.0M in Q4 2023
Protolabs Q3 revenue down 3.9% YoY to $126M; GAAP EPS $0.29, non-GAAP $0.47
Revenue $125.6M, down 3.9% YoY from record $130.7M in Q3 2023.
Proto Labs approves Germany facility closures; expects $4.5M-$6M restructuring charges
Plan closes prototype injection molding plant in Eschenlohe, Germany, and stops DMLS 3D printing in Putzbrunn.
Proto Labs finalizes separation agreement with former EMEA VP Bjoern Klaas
Bjoern Klaas's termination date set at November 30, 2024.
Protolabs Q2 2024 revenue $125.6M (+2.8%); GAAP EPS $0.18 vs loss $0.01 YoY
Revenue $125.6M, up 2.8% YoY; Network revenue $24.7M, up 22.0%.
Proto Labs EMEA VP Bjoern Klaas departs; transition terms under discussion
Bjoern Klaas exited his role as VP and General Manager of EMEA region on July 22, 2024.
All 8 director nominees elected; highest votes for Robert Bodor (19.3M for) and Stacy Greiner (19.3M for).
Proto Labs Q1 revenue $127.9M (+1.6% YoY); GAAP EPS $0.20, Non-GAAP EPS $0.40
Revenue $127.9M (+1.6% YoY); Protolabs Network revenue $23.9M (+38.9% YoY).
Protolabs Q4 revenue up 8.2% to $125M; record FY 2023 revenue of $504M; guides 2024 $495-$525M
Q4 2023 revenue $125.0M (+8.2% YoY); Network revenue $22.5M (+52% YoY).
Record revenue $130.7M; non-GAAP EPS $0.51; network revenue up 87% YoY
Record Q3 revenue of $130.7M, up 7.4% YoY.
Proto Labs Q2 revenue down 3.7% to $122.3M; GAAP loss $0.01, non-GAAP EPS $0.33
Revenue of $122.3M, down 3.7% YoY from $126.9M; network revenue $20.2M, up 79.3% YoY.
Proto Labs shareholders approve LTIP amendment adding 559,500 shares
Amendment to 2022 Long-Term Incentive Plan approved: 19.4M for, 406k against; shares increased by 559,500.
Proto Labs Q1 2023 revenue $125.9M (+1.4% YoY); EPS $0.10 GAAP, $0.30 non-GAAP
Revenue $125.9M, up 1.4% YoY from $124.2M.
Q4 revenue $115.6M (-6.5% YoY); full-year record $488.4M.
Proto Labs increases share repurchase authorization by $50M to $200M, extends to 2024
Board authorized increase from $150M to $200M; program extended through December 31, 2024.
Proto Labs amends bylaws tightening proxy solicitation and director nomination rules
Board may now reschedule, postpone, or cancel any previously scheduled shareholder meeting (except special meetings on demand) with public notice.
Proto Labs Q3 2022 revenue $121.7M, GAAP EPS $0.14, Non-GAAP EPS $0.40
Revenue of $121.7M, down 2.9% YoY from $125.3M in Q3 2021.
Proto Labs shareholders approve 2022 Long-Term Incentive Plan; 1.24M shares authorized
Approved at Aug 29, 2022 special meeting: 21,441,768 for, 336,026 against, 32,670 abstain.
Proto Labs Q2 revenue $126.9M (record, +3.1% YoY); GAAP EPS $0.09, non-GAAP $0.46
Record revenue of $126.9M, up 3.1% YoY from $123.0M in Q2 2021.
Proto Labs appoints Daniel Schumacher as CFO effective June 3, 2022
Dan Schumacher, previously interim CFO since Dec 2021, named permanent CFO.
Proto Labs to close Japan manufacturing facility; expects $7M-$9.5M in restructuring charges
Total restructuring charges expected $7.0M-$9.5M: severance $2.5M-$3.5M, asset write-down $3.5M-$4.5M, goodwill $1.0M-$1.5M.
All 8 director nominees elected; each received over 21 million votes (96%+ of votes cast).
Protolabs Q1 2022 revenue $124.2M (+6.9% YoY); GAAP EPS $0.19, non-GAAP EPS $0.38
Revenue $124.2M, up 6.9% from $116.1M in Q1 2021.
Proto Labs CTO Arthur Baker stepping down; CEO Bodor to serve as interim
Arthur R. Baker III, Chief Technology Officer, will depart effective April 15, 2022.
Proto Labs Q4 revenue $123.6M, up 18% YoY; record annual revenue $488.1M
Q4 revenue $123.6M (+17.5% YoY); net income $11.9M ($0.43 diluted EPS).
Proto Labs increases stock repurchase authorization by $50M to $150M total
Board approved $50M increase on Dec 8, 2021; total authorization now $150M through Dec 31, 2023.
Proto Labs elects Stacy Greiner to board of directors, effective Nov. 15, 2021
Greiner is General Manager, North America Sales & Marketing at Dun & Bradstreet.
Proto Labs CFO John Way resigns; Dan Schumacher named interim CFO
John Way resigns as CFO effective Nov 30, 2021, to pursue another opportunity.
Proto Labs reports Q3 2021 record revenue of $125.3M, up 17% YoY; EPS $0.17 GAAP
Revenue of $125.3M in Q3 2021, up 16.6% from $107.5M in Q3 2020.
Proto Labs Q2 2021 revenue $123.0M (+15.5% YoY), record revenue, EPS $0.47
Revenue $123.0M, up 15.5% YoY from $106.6M.
On May 6, 2026, Proto Labs, Inc. (the “Company”) announced that Michael R. Kenison, Chief Operations Officer, intends to retire effective July 1, 2026.
Effective May 18, 2026, Bernardo Parlange was appointed as the Company’s Chief Commercial Officer, a newly created role where Mr. Parlange will oversee the Company’s global commercial strategy, including sales, marketing, and customer success.
Robert Bodor ceased to be the President and Chief Executive Officer of the Company, effective as of May 20, 2025
Robert Bodor, who ceased to be the President and Chief Executive Officer and a director of the Company effective as of the Transition Date.
the Board of Directors (the “Board”) of the Company has appointed Suresh Krishna to serve as the Company’s President and Chief Executive Officer, effective May 20, 2025
The Board has also appointed Mr. Krishna to serve as a director of the Company
Robert Bodor, who ceased to be the President and Chief Executive Officer and a director of the Company effective as of the Transition Date.
Pursuant to the Settlement Agreement, Mr. Klaas’ termination date will be November 30, 2024 (the “Termination Date”).
On July 22, 2024, Bjoern Klaas, Vice President and General Manager of the EMEA region, exited his position as vice president and is no longer an executive officer of Proto Labs, Inc.
On June 3, 2022, Proto Labs, Inc. (the “Company”) appointed Daniel Schumacher, age 47, as Chief Financial Officer (“CFO”), effective immediately.
Upon the Effective Date, Dr. Robert Bodor, Chief Executive Officer of the Company, will serve as the interim Chief Technology Officer while the Company conducts a search for a new leader.
On March 16, 2022, Proto Labs, Inc. (the “Company”) announced that Arthur R. Baker III, Chief Technology Officer, is stepping down from his role with the Company, effective April 15, 2022 (the “Effective Date”).
Max materiality 0.75 · Median 0.60 · Most common event earnings